Neuropsychotoxicity of abused drugs: Involvement of matrix metalloproteinase-2 and-9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents

被引:38
作者
Mizoguchi, Hiroyuki [1 ,2 ,3 ,4 ]
Yamada, Kiyofumi [1 ,2 ,3 ]
Nabeshimal, Toshitaka [1 ,2 ,5 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Nagoya, Aichi 4668560, Japan
[2] Nagoya Univ, Grad Sch Med, Hosp Pharm, Nagoya, Aichi 4668560, Japan
[3] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 9201192, Japan
[4] Nagoya Univ, Environm Med Res Inst, Futurist Environm Simulat Ctr, Nagoya, Aichi 4648601, Japan
[5] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan
关键词
drugs of abuse; matrix metalloproteinase; tissue inhibitor of matrix metalloproteinase; methamphetamine; dopamine;
D O I
10.1254/jphs.FM0070139
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) function to remodel the pericellular environment. We have investigated the role of the MMP/TIMP system in methamphetamine (METH) dependence in rodents, in which the remodeling of neural circuits may be crucial. Repeated METH treatment induced behavioral sensitization, which was accompanied by an increase in MMP-2/-9/TIMP-2 activity in the brain. An antisense TIMP-2 oligonucleotide enhanced the sensitization, which was associated with a potentiation of the METH-induced release of dopamine in the nucleus accumbens (NAc). MMP-2/-9 inhibitors blocked the METH-induced behavioral sensitization and conditioned place preference (CPP), a measure of the rewarding effect of a drug, and reduced the METH-increased dopamine release in the NAc. In MMP-2- and MMP-9-deficient mice, METH-induced behavioral sensitization and CPP as well as dopamine release were attenuated. The MMP/TIMP system may be involved in METH-induced sensitization and reward by regulating extracellular dopamine levels.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 42 条
  • [1] ECM DEGRADATION BY CULTURED HUMAN MESANGIAL CELLS IS MEDIATED BY A PA/PLASMIN/MMP-2 CASCADE
    BARICOS, WH
    CORTEZ, SL
    ELDAHR, SS
    SCHNAPER, HW
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (04) : 1039 - 1047
  • [2] Addiction, dopamine, and the molecular mechanisms of memory
    Berke, JD
    Hyman, SE
    [J]. NEURON, 2000, 25 (03) : 515 - 532
  • [3] Activator of G protein signaling 3: A gatekeeper of cocaine sensitization and drug seeking
    Bowers, MS
    McFarland, K
    Lake, RW
    Peterson, YK
    Lapish, CC
    Gregory, ML
    Lanier, SM
    Kalivas, PW
    [J]. NEURON, 2004, 42 (02) : 269 - 281
  • [4] BOWYER JF, 1987, J PHARMACOL EXP THER, V241, P27
  • [5] Brown Travis E, 2007, Learn Mem, V14, P214, DOI 10.1101/lm.476207
  • [6] Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
    Ethell, Iryna M.
    Ethell, Douglas W.
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (13) : 2813 - 2823
  • [7] Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex
    Goldstein, RZ
    Volkow, ND
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (10) : 1642 - 1652
  • [8] Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain
    Ishikawa, Kazuhiro
    Nitta, Atsumi
    Mizoguchi, Hiroyuki
    Mohri, Akihiro
    Murai, Rina
    Miyamoto, Yoshiaki
    Noda, Yukihiro
    Kitaichi, Kiyoyuki
    Yamada, Kiyofumi
    Nabeshima, Toshitaka
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (04) : 407 - 415
  • [9] Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice
    Kamei, H
    Nagai, T
    Nakano, H
    Togan, Y
    Takayanagi, M
    Takahashi, K
    Kobayashi, K
    Yoshida, S
    Maeda, K
    Takuma, K
    Nabeshima, T
    Yamada, K
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (01) : 75 - 84
  • [10] N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux
    Khoshbouei, H
    Sen, N
    Guptaroy, B
    Johnson, L
    Lund, D
    Gnegy, ME
    Galli, A
    Javitch, JA
    [J]. PLOS BIOLOGY, 2004, 2 (03): : 387 - 393